Analytical Data
-
Gene name
DAPK2
- Application
-
Alternative Names
DRP-1; DAP-kinase-related protein 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UIK4
-
Expression Region
Met1~Thr235
-
Molecular Weight
31kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DAPK2 (Death-Associated Protein Kinase 2) is a serine/threonine kinase that plays a critical role in various cellular processes, including apoptosis, autophagy, and immune responses. It is a member of the DAPK family, which is known to be involved in tumor suppression and the regulation of cancer cell survival. The study of DAPK2 has gained prominence due to its potential implications in cancer biology, neurodegenerative diseases, and inflammatory disorders. Recent research has highlighted its involvement in different signaling pathways, making it a target of interest for therapeutic interventions. To further understand its biological functions and mechanisms, the production of recombinant DAPK2 protein is crucial. Recombinant protein enables researchers to study its enzymatic activities, structural properties, and interactions with other cellular molecules under controlled laboratory conditions. This facilitates the development of assays to assess its role in disease models and therapeutic applications, paving the way for novel strategies in cancer treatment and other diseases linked to DAPK2 dysregulation. Furthermore, as a biopharmaceutical target, understanding DAPK2's structural and functional characteristics through recombinant studies can aid in the design of small-molecule inhibitors or modulators, potentially leading to new drug development avenues. Consequently, the analysis of recombinant DAPK2 protein not only expands our knowledge of its biological significance but also enhances the potential for translational research aimed at addressing critical health challenges.
